Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Korean J Prev Med > Accepted Articles > Article
Original Article Healthcare Utilization and Discrepancies by Income Level among Patients with Newly Diagnosed Type 2 Diabetes: An Analysis of National Health Insurance Sample Cohort Data
Eun Jee Park1orcid , Nam Ju Ji2orcid , Chang Hoon You2orcid , Weon-Young Lee1corresp_iconorcid

DOI: https://doi.org/10.3961/jpmph.24.165 [Accepted]
Published online: August 20, 2024
  • 227 Views
  • 17 Download
  • 0 Crossref
  • 0 Scopus
1Department of Preventive Medicine, College of Medicine, Chung-Ang University, Seoul, Korea
2Seoul Public Health Research Institute, Seoul Medical Center, Seoul, Korea
Corresponding author:  Weon-Young Lee,
Email: wylee@cau.ac.kr
Received: 26 March 2024   • Revised: 19 July 2024   • Accepted: 22 July 2024

Objectives
The use of qualitative healthcare services or its discrepancy between different income levels of the type 2 diabetes(T2D) patients has seldom been studied concurrently. The present study is unique that regarding T2D patients of early stages of diagnosis. Aimed to assess the utilization of qualitative healthcare services and influence of income levels on the inequality of care among newly diagnosed patients with T2D.
Methods
A retrospective cohort study of 7590 patients was conducted by the NHIS-NSC2 from 2002 to 2015. Insured employee in 2013 with no history of T2D between 2002 and 2012 were included. The standard of diabetes care includes HbA1c (4 times/year), eyes (once /year) and lipid abnormalities (once/year). Multivariate logistic regression analysis was performed to examine the difference between income levels and inequality of care.
Results
From years 1 to 3, rates of appropriate screening fell from 16.9% to 14.1% (HbA1c), 15.8% to 14.5% (eye), and 59.2% to 33.2% (lipid abnormalities). Relative to income class 5 (the highest-income group), HbA1 screening was significantly less common in class 2 (year 2: OR, 0.785; 95% CI, 0.61-0.99; year 3: OR, 0.793; 95% CI, 0.69-0.91). In year 1, lipid screening was less common in class 1 (OR, 0.843; 95% CI, 0.73-0.98) than in class 5, a trend that continued in year 2. Eye screening rates were consistently lower in class 1 than in class 5 (year 1: OR, 0.734; 95% CI, 0.604-0.890; year 2: OR, 0.628; 95% CI, 0.503-0.779; year 3: OR, 0.814; 95% CI, 0.668-0.989).
Conclusions
Newly diagnosed T2D patients have shown low rate of HbA1c and screening for diabetic-related complications and experienced inequality in relation to receiving qualitative diabetes care by income levels.


JPMPH : Journal of Preventive Medicine and Public Health
TOP